FDA approves niraparib for first-line maintenance of advanced ovarian cancer
Hematology / Oncology News Burst
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Hematology | Ovarian Cancer | Ovaries